Does IFOSFAMIDE Cause Malignant neoplasm progression? 671 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 671 reports of Malignant neoplasm progression have been filed in association with IFOSFAMIDE (IFEX). This represents 4.0% of all adverse event reports for IFOSFAMIDE.
671
Reports of Malignant neoplasm progression with IFOSFAMIDE
4.0%
of all IFOSFAMIDE reports
210
Deaths
120
Hospitalizations
How Dangerous Is Malignant neoplasm progression From IFOSFAMIDE?
Of the 671 reports, 210 (31.3%) resulted in death, 120 (17.9%) required hospitalization, and 43 (6.4%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IFOSFAMIDE. However, 671 reports have been filed with the FAERS database.
What Other Side Effects Does IFOSFAMIDE Cause?
Off label use (2,281)
Febrile neutropenia (2,225)
Disease progression (1,912)
Neutropenia (1,509)
Drug ineffective (1,331)
Thrombocytopenia (1,227)
Anaemia (1,067)
Product use in unapproved indication (890)
Pyrexia (752)
Sepsis (712)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which IFOSFAMIDE Alternatives Have Lower Malignant neoplasm progression Risk?
IFOSFAMIDE vs IGURATIMOD
IFOSFAMIDE vs ILOPERIDONE
IFOSFAMIDE vs ILOPROST
IFOSFAMIDE vs IMATINIB
IFOSFAMIDE vs IMBRUVICA